- Home
- KROS vs UFCS Comparison
KROS vs UFCS Comparison
Compare KROS & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- UFCS
- Stock Information
- Founded
- KROS 2015
- UFCS 1946
- Country
- KROS United States
- UFCS United States
- Employees
- KROS N/A
- UFCS N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- UFCS Property-Casualty Insurers
- Sector
- KROS Health Care
- UFCS Finance
- Exchange
- KROS Nasdaq
- UFCS Nasdaq
- Market Cap
- KROS 460.6M
- UFCS 642.7M
- IPO Year
- KROS 2020
- UFCS N/A
- Fundamental
- Price
- KROS $11.13
- UFCS $25.29
- Analyst Decision
- KROS Buy
- UFCS Hold
- Analyst Count
- KROS 11
- UFCS 1
- Target Price
- KROS $45.33
- UFCS $26.00
- AVG Volume (30 Days)
- KROS 2.1M
- UFCS 132.1K
- Earning Date
- KROS 02-26-2025
- UFCS 02-11-2025
- Dividend Yield
- KROS N/A
- UFCS 2.56%
- EPS Growth
- KROS N/A
- UFCS N/A
- EPS
- KROS N/A
- UFCS 1.94
- Revenue
- KROS $651,000.00
- UFCS $1,207,451,000.00
- Revenue This Year
- KROS $303.27
- UFCS N/A
- Revenue Next Year
- KROS N/A
- UFCS $11.31
- P/E Ratio
- KROS N/A
- UFCS $12.86
- Revenue Growth
- KROS 8037.50
- UFCS 10.95
- 52 Week Low
- KROS $9.78
- UFCS $18.04
- 52 Week High
- KROS $73.00
- UFCS $31.70
- Technical
- Relative Strength Index (RSI)
- KROS 25.01
- UFCS 34.07
- Support Level
- KROS $11.04
- UFCS $24.11
- Resistance Level
- KROS $11.36
- UFCS $26.15
- Average True Range (ATR)
- KROS 0.53
- UFCS 0.82
- MACD
- KROS 1.15
- UFCS -0.05
- Stochastic Oscillator
- KROS 37.80
- UFCS 25.15
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About UFCS United Fire Group Inc.
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.